Language selection

Government of Canada / Gouvernement du Canada

Search

Respiratory Virus Report, Week 11 - ending March 16, 2024

Download in PDF format
(750 KB, 13 pages)

Organization: Public Health Agency of Canada

Please note that the Respiratory Virus Detection Surveillance System (RVDSS) is a sentinel laboratory surveillance system that does not capture all respiratory virus testing performed in Canada; differences may exist between the data presented in this report and provincial/territorial epidemiological reports. SARS-CoV-2 laboratory data is included in this report to facilitate the comparison of positivity with other respiratory viruses. Interpretation should be made with caution as testing practices differ among viruses.

For additional SARS-CoV-2 surveillance information, please refer to the COVID-19 epidemiology update.

Overall summary

In week 11 (week ending March 16, 2024) in Canada, participating RVDSS laboratories reported 1,972 detections of SARS-CoV-2 from 32,252 tests (6.1% positive). Among non-SARS-CoV-2 respiratory viruses, where test volumes are lower (range of 6,719 to 25,733 tests), activity of influenza and human coronavirus are highest.

  • National SARS-CoV-2 percent positivity has been decreasing since mid-December 2023.
  • Influenza A percent positivity has decreased in recent weeks (1,156 detections; 4.5% positive) and is now lower than influenza B which is currently stable (1,262 detections; 4.9% positive).
  • RSV percent positivity has decreased in recent weeks (718 detections; 3.2% positive).
  • Among other respiratory viruses, human coronavirus percent positivity is above average levels for of this time of year (485 detections; 7.2% positive).
  • 34/35 sentinel laboratories reported surveillance data

On this page

Abbreviations:
ADV
Adenovirus
Atl
Atlantic Canada
BC
British Columbia
Can
Canada
EORLA
Eastern Ontario Regional Laboratory Association
EV/RV
Enterovirus/Rhinovirus
Flu
Influenza
Flu A(H1)pdm09
Influenza A(H1N1)pdm09
Flu A(H3)
Influenza A(H3N2)
Flu A(UnS)
Influenza A(Unsubtyped)
HCoV
Human coronavirus 229E/OC43/NL63/HKU1
HMPV
Human metapneumovirus
HPIV
Human parainfluenza virus
HSC
Health Sciences Centre
N.C.
Data not collected
N.R.
Data not reported for current week
ON
Ontario
PR
Prairies
P.H.O.L.
Public Health Ontario Laboratory
QC
Quebec
RSV
Respiratory syncytial virus
RVDSS
Respiratory Virus Detection Surveillance System
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Terr
Territories of Canada
UHN
University Health Network

Respiratory virus detections

Table 1: Respiratory virus detections for the week ending March 16, 2024 (surveillance week 2024-11)
Reporting Laboratory SARS-CoV-2 Tested SARS-CoV-2 Positive Flu Tested A(H1)pdm09 Positive A(H3) Positive A(UnS) Positive Total Flu A Positive Total Flu B Positive RSV Tested RSV Positive HPIV Tested HPIV 1 Positive HPIV 2 Positive HPIV 3 Positive HPIV 4 Positive Other HPIV Positive ADV Tested ADV Positive HMPV Tested HMPV Positive EV/RV Tested EV/RV Positive HCoV Tested HCoV Positive
Newfoundland 565 37 452 0 0 19 19 7 452 36 452 1 6 0 0 0 452 5 452 33 452 16 452 21
Prince Edward Island 275 21 265 0 0 9 9 43 265 20 24 0 0 0 0 0 24 2 24 2 24 4 24 4
Nova Scotia 1306 127 1251 0 0 127 127 31 1099 23 34 1 0 1 0 0 34 0 34 2 34 5 34 2
New Brunswick 1200 46 1202 14 1 21 36 76 1203 76 116 0 0 2 1 0 116 2 116 11 116 16 116 4
Atlantic 3346 231 3170 14 1 176 191 157 3019 155 626 2 6 3 1 0 626 9 626 48 626 41 626 31
Région Nord-Est 1436 52 1181 0 0 54 54 63 538 29 76 1 0 5 0 0 76 4 75 6 N.C. N.C. 76 13
Québec-Chaudière-Appalaches 1433 40 1186 0 0 63 63 134 1099 52 422 0 0 6 0 0 435 7 422 26 N.C. N.C. 305 28
Centre-du-Québec 2038 68 1495 0 0 129 129 89 687 24 18 0 0 0 0 0 18 0 18 1 N.C. N.C. 18 0
Montréal-Laval 2104 56 2122 0 0 125 125 55 1116 38 614 0 0 12 0 0 614 8 617 26 N.C. N.C. 614 32
Ouest du Québec 1134 32 543 0 0 28 28 30 539 17 11 0 0 1 0 0 11 0 11 2 N.C. N.C. 11 1
Montérégie 1238 37 1136 0 0 61 61 27 1129 30 11 0 0 0 0 0 11 0 11 0 N.C. N.C. 11 0
Province of Québec 9383 285 7663 0 0 460 460 398 5108 190 1152 1 0 24 0 0 1165 19 1154 61 N.C. N.C. 1035 74
P.H.O.L. - Ottawa 281 42 287 11 1 16 28 5 287 2 185 0 0 0 0 19 185 0 185 9 185 12 185 25
EORLA 914 40 566 0 0 35 35 49 566 8 38 0 0 1 0 0 38 2 38 5 38 6 38 3
P.H.O.L. - Kingston 128 19 93 2 0 1 3 0 93 1 59 0 0 0 0 3 59 0 59 4 59 3 59 12
UHN / Mount Sinai Hospital 851 22 561 1 0 7 8 6 561 6 72 0 0 3 0 0 72 0 72 0 72 5 72 4
P.H.O.L. - Toronto 350 20 890 22 2 27 50 18 890 4 868 0 0 0 0 52 869 15 868 69 868 50 868 110
Sick Kids Hospital - Toronto N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R.
Shared Hospital Laboratory 1751 34 1370 17 4 8 29 39 1370 8 1362 0 0 0 0 19 1362 9 1375 27 1375 44 1375 27
P.H.O.L. - Sault Ste. Marie 4 0 11 0 0 0 0 0 11 1 11 0 0 0 0 0 11 0 11 0 11 0 11 2
P.H.O.L. - Timmins 44 22 55 0 0 0 0 2 55 1 37 0 0 0 0 0 37 0 37 2 37 0 37 3
St. Joseph's - London 756 28 636 0 0 19 19 26 636 3 70 0 0 0 0 1 70 1 70 5 70 6 70 4
P.H.O.L. - London 368 62 332 17 1 5 23 12 332 2 284 0 0 0 0 16 284 0 284 14 284 13 284 39
P.H.O.L. - Orillia 11 2 14 0 0 0 0 0 14 0 13 0 0 0 0 1 13 0 13 0 13 1 13 7
P.H.O.L. - Thunder Bay 37 7 38 0 0 0 0 1 38 1 33 0 0 0 0 1 33 0 33 3 33 2 33 6
P.H.O.L. - Sudbury 16 0 27 3 0 1 4 0 27 0 26 0 0 0 0 0 26 0 26 1 26 1 26 11
P.H.O.L. - Hamilton 153 35 163 3 0 0 3 6 163 2 147 0 0 0 0 9 147 2 147 9 147 15 147 10
P.H.O.L. - Peterborough 42 0 66 0 0 2 2 2 66 0 57 0 0 0 0 3 57 1 57 3 57 2 57 11
St. Joseph's - Hamilton 1711 60 1608 0 0 64 64 88 1608 15 1608 0 0 38 0 0 1608 7 1608 76 1608 85 0 0
Sault Area Hospital 170 22 120 1 3 2 6 3 120 5 88 1 0 1 0 0 88 0 88 2 88 5 88 3
Province of Ontario 7587 415 6837 77 11 187 274 257 6837 59 4958 1 0 43 0 124 4959 37 4971 229 4971 250 3363 277
Manitoba 1549 187 1115 2 0 8 10 38 1115 23 94 0 0 1 0 0 94 4 124 8 94 8 124 12
Saskatchewan 1727 103 1236 0 0 23 23 153 1017 58 407 1 0 13 3 0 407 7 407 22 407 21 407 27
Alberta 4466 281 1543 11 6 1 26 101 1504 51 323 0 0 12 0 0 323 4 294 0 318 28 323 17
Prairies 7742 571 3894 13 6 32 59 292 3636 132 824 1 0 26 3 0 824 15 825 30 819 57 854 56
British Columbia 3901 448 3941 26 11 4 171 138 3799 141 873 1 4 28 3 0 873 22 873 62 841 108 841 47
Yukon 46 2 37 1 0 0 1 1 37 1 N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C.
Northwest Territories 33 1 33 0 0 0 0 3 33 9 N.C. N.C. N.C. N.C. N.C. N.C. 33 1 33 1 33 6 N.C. N.C.
Nunavut 214 19 158 0 0 0 0 16 158 31 N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C.
Territories 293 22 228 1 0 0 1 20 228 41 N.C. N.C. N.C. N.C. N.C. N.C. 33 1 33 1 33 6 N.C. N.C.
CANADA 32252 1972 25733 131 29 859 1156 1262 22627 718 8433 6 10 124 7 124 8480 103 8482 431 7290 462 6719 485

The data in the RVDSS report represent surveillance data available at the time of writing. Data missing from the current week are denoted by N.R. Data not collected by reporting lab denoted by N.C.

Some specimens from Yukon (YT) are sent to reference laboratories in British Columbia and reported results reflect specimens identified as originating from YT.

Results from British Columbia comprise of specimens from the following sites: Children's and Women's Hospital Laboratory, Fraser Health Medical Microbiology Laboratory, Island Health, Providence Health Care, Vancouver Coastal Health sites, Victoria General Hospital, BCCDC Public Health Laboratory, Interior Health Authority sites and Northern Health Authority sites.

Due to different testing protocols of laboratories across Canada, influenza A subtype detection counts may not be included in total influenza A detection counts. Total influenza A and B positive counts are used to calculate percentage of tests positive.

Delays in the reporting of data may cause data to change retrospectively.

Table 2: Cumulative respiratory virus detections from August 27, 2023 to March 16, 2024 (surveillance weeks 2023-35 to 2024-11)
Reporting Laboratory SARS-CoV-2 Tested SARS-CoV-2 Positive Flu Tested A(H1)pdm09 Positive A(H3) Positive A(UnS) Positive Total Flu A Positive Total Flu B Positive RSV Tested RSV Positive HPIV Tested HPIV 1 Positive HPIV 2 Positive HPIV 3 Positive HPIV 4 Positive Other HPIV Positive ADV Tested ADV Positive HMPV Tested HMPV Positive EV/RV Tested EV/RV Positive HCoV Tested HCoV Positive
Newfoundland 18172 2708 13242 0 0 1299 1299 68 13242 857 13242 16 64 23 100 0 13242 226 13242 233 13242 1070 13242 307
Prince Edward Island 6692 728 4164 0 0 535 535 106 4164 350 465 3 0 1 8 0 464 27 454 13 464 120 448 22
Nova Scotia 42000 8149 28482 0 0 2431 2431 270 23490 1360 1002 16 2 4 10 0 1002 39 995 7 1002 217 1001 11
New Brunswick 31970 3751 29554 877 25 1843 2745 460 29150 1770 2597 7 4 7 28 0 2597 97 2597 58 2597 505 2597 106
Atlantic 98834 15336 75442 877 25 6108 7010 904 70046 4337 17306 42 70 35 146 0 17305 389 17288 311 17305 1912 17288 446
Région Nord-Est 50013 6976 44513 5 0 4651 4656 392 17466 1301 2221 15 12 17 16 0 2221 96 2172 79 N.C. N.C. 2221 79
Québec-Chaudière-Appalaches 59037 9252 38252 0 0 5359 5359 832 36753 2506 14676 21 9 25 13 0 15102 472 14676 399 N.C. N.C. 12135 389
Centre-du-Québec 73011 12314 34158 0 0 4285 4285 482 20613 1527 1076 15 8 15 7 0 1076 54 1076 43 N.C. N.C. 1105 39
Montréal-Laval 87857 13767 70085 5 2 6338 6345 303 45630 2743 24146 94 39 167 24 0 24146 470 24213 498 N.C. N.C. 24146 801
Ouest du Québec 48432 9968 20142 4 0 1949 1953 187 19946 1066 558 11 3 11 7 0 558 41 558 15 N.C. N.C. 558 25
Montérégie 46706 7937 36823 0 0 3065 3065 174 35751 1691 199 1 0 0 1 0 199 6 199 3 N.C. N.C. 199 3
Province of Québec 365056 60214 243973 14 2 25647 25663 2370 176159 10834 42876 157 71 235 68 0 43302 1139 42894 1037 N.C. N.C. 40364 1336
P.H.O.L. - Ottawa 10105 3600 6896 283 54 171 385 23 6890 130 4148 0 0 0 0 89 4148 12 4146 66 4148 415 4146 196
EORLA 37619 4420 17364 0 0 1537 1537 246 17364 1108 1132 2 5 17 4 0 1107 13 1132 23 1132 207 1132 32
P.H.O.L. - Kingston 6978 2039 3868 128 17 94 213 4 3868 168 2714 0 0 0 0 48 2714 11 2714 14 2714 326 2714 79
UHN / Mount Sinai Hospital 31864 2977 19857 41 10 527 578 63 19857 214 1146 0 0 14 2 0 1146 1 1146 3 1146 52 1146 41
P.H.O.L. - Toronto 17933 5384 31988 1131 900 325 1711 198 31979 1039 29254 0 0 0 0 889 29262 338 29239 522 29254 2765 29239 1352
Sick Kids Hospital - Toronto 3527 292 3139 100 95 20 215 26 3139 305 3139 14 12 55 19 0 3139 77 3139 65 3139 550 3139 88
Shared Hospital Laboratory 50632 4475 42781 812 514 283 1609 277 42787 1333 42584 0 0 0 0 278 36930 309 42641 208 42686 1410 42663 474
P.H.O.L. - Sault Ste. Marie 423 186 514 49 3 16 62 0 514 45 360 0 0 0 0 5 360 1 360 0 360 21 360 35
P.H.O.L. - Timmins 1054 315 1042 58 10 27 84 2 1042 61 829 0 0 0 0 22 829 4 829 8 829 50 829 26
St. Joseph's - London 25859 3417 13746 0 0 948 948 179 13746 710 1928 0 0 0 0 22 1947 30 1947 23 1949 222 1947 50
P.H.O.L. - London 13804 4073 10170 473 141 160 589 76 10167 468 8117 0 0 0 0 219 8117 35 8115 83 8117 698 8115 300
P.H.O.L. - Orillia 548 144 1235 71 17 11 99 0 1232 74 1170 0 0 0 0 30 1170 15 1170 18 1170 145 1170 24
P.H.O.L. - Thunder Bay 1738 494 1071 57 0 8 37 5 1068 29 899 0 0 0 0 27 899 5 899 27 899 56 899 17
P.H.O.L. - Sudbury 671 238 798 39 1 21 61 1 796 22 555 0 0 0 0 14 556 1 555 2 555 44 555 33
P.H.O.L. - Hamilton 6813 2072 5535 139 65 87 237 33 5534 172 4144 0 0 0 0 130 4144 77 4143 77 4144 536 4143 180
P.H.O.L. - Peterborough 2153 665 2172 204 204 69 147 14 2162 221 1725 0 0 0 0 55 1725 36 1725 29 1725 279 1725 51
St. Joseph's - Hamilton 55752 5694 49352 0 0 3047 3047 514 49352 1744 49352 0 0 368 0 0 49352 307 49352 494 49352 2838 0 0
Sault Area Hospital 5496 767 3686 173 14 51 238 12 3679 196 2889 26 0 14 17 0 2840 33 2840 12 2840 247 2850 56
Province of Ontario 272969 41252 215214 3758 2045 7402 11797 1673 215176 8039 156085 42 17 468 42 1828 150385 1305 156092 1674 156159 10861 106772 3034
Manitoba 47474 7020 35724 142 11 1818 1971 222 35724 1304 2704 0 10 18 41 0 2704 119 3479 130 2704 511 3479 109
Saskatchewan 61053 7136 41256 117 10 5323 5450 1108 37116 1458 13333 30 9 58 23 0 13333 263 13333 723 13333 1287 13333 310
Alberta 158731 19225 135001 11697 720 581 13070 2087 125899 5839 37155 126 89 339 3 0 37146 442 36091 26 36577 3374 37154 818
Prairies 267258 33381 211981 11956 741 7722 20491 3417 198739 8601 53192 156 108 415 67 0 53183 824 52903 879 52614 5172 53966 1237
British Columbia 111733 15221 112690 3987 744 252 8337 751 110044 5653 26178 112 170 226 167 0 26180 799 26065 965 25108 3867 25085 711
Yukon 1595 176 1037 34 15 0 59 4 1028 46 N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C.
Northwest Territories 1107 70 1046 166 6 1 173 45 1046 167 N.C. N.C. N.C. N.C. N.C. N.C. 847 43 847 9 1046 128 N.C. N.C.
Nunavut 3774 329 2629 426 30 52 508 60 2629 398 N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C.
Territories 6476 575 4712 626 51 53 740 109 4703 611 N.C. N.C. N.C. N.C. N.C. N.C. 847 43 847 9 1046 128 N.C. N.C.
CANADA 1122326 165979 864012 21218 3608 47184 74038 9224 774867 38075 295637 509 436 1379 490 1828 291202 4499 296089 4875 252232 21940 243475 6764

The data in the RVDSS report represent surveillance data available at the time of writing. Data not collected by reporting lab denoted by N.C.

Some specimens from Yukon (YT) are sent to reference laboratories in British Columbia and reported results reflect specimens identified as originating from YT.

Results from British Columbia comprise of specimens from the following sites: Children's and Women's Hospital Laboratory, Fraser Health Medical Microbiology Laboratory, Island Health, Providence Health Care, Vancouver Coastal Health sites, Victoria General Hospital, BCCDC Public Health Laboratory, Interior Health Authority sites and Northern Health Authority sites.

Due to different testing protocols of laboratories across Canada, influenza A subtype detection counts may not be included in total influenza A detection counts. Total influenza A and B positive counts are used to calculate percentage of tests positive.

Delays in the reporting of data may cause data to change retrospectively. Due to these delays, the sum of weekly report totals do not add up to cumulative totals.

Positive respiratory virus tests historical comparison

Figure 1: Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza, and respiratory syncytial virus tests (%) reported by participating laboratories in Canada by surveillance week compared to average and range from 2014-2015 to 2019-2020 season
Figure 1

Shaded area represents the maximum and minimum % of respiratory virus tests positive reported by week from seasons 2014-2015 to 2019-2020

Note: Changes to testing practices during the COVID-19 pandemic may cause substantial changes to indicator estimates from previous years. Collection of laboratory testing practice meta-data to understand these changes is ongoing. Interpret trends with caution.

Note: SARS-CoV-2 surveillance was integrated into RVDSS at the beginning of the 2022-2023 season; no prior data is available for historical comparison.

Note: Data from week 11 of the 2019-2020 season onwards are excluded from the historical comparison due to the COVID-19 pandemic.

Figure 1: Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza, and respiratory syncytial virus tests (%) reported by participating laboratories in Canada by surveillance week compared to average and range from 2014-2015 to 2019-2020 season
Week Week end 2023-2024 SARS-CoV-2% 2022-2023 SARS-CoV-2% 2023-2024 A% 2022-2023 A% 2021-2022 A% Max A% Base Min A% Base Av A% Base 2023-2024 B% 2022-2023 B% 2021-2022 B% Max B% Base Min B% Base Av B% Base 2023-2024 RSV% 2022-2023 RSV% 2021-2022 RSV% Max RSV% Base Min RSV% Base Av RSV% Base
35 2023-09-02 14.40 13.40 0.69 0.18 0.04 1.60 0.11 0.67 0.06 0.02 0.00 0.28 0.00 0.14 0.58 1.12 4.43 1.34 0.38 0.61
36 2023-09-09 15.92 13.07 0.43 0.14 0.01 2.11 0.23 0.99 0.06 0.04 0.00 0.55 0.00 0.15 0.71 1.12 6.61 1.09 0.22 0.62
37 2023-09-16 16.49 12.74 0.48 0.23 0.03 1.59 0.35 0.87 0.03 0.01 0.00 0.19 0.04 0.12 0.82 1.06 7.59 1.37 0.38 0.65
38 2023-09-23 18.60 13.62 0.51 0.48 0.00 2.15 0.43 1.17 0.02 0.02 0.00 0.21 0.00 0.14 1.15 1.47 7.16 1.24 0.37 0.67
39 2023-09-30 19.59 14.44 0.51 0.67 0.01 2.65 0.50 1.52 0.09 0.03 0.00 0.29 0.09 0.18 1.14 2.14 8.48 1.29 0.51 0.72
40 2023-10-07 19.81 15.06 0.64 0.96 0.00 2.17 1.01 1.58 0.05 0.03 0.02 0.20 0.05 0.11 1.35 2.54 8.53 1.39 0.34 0.71
41 2023-10-14 17.55 16.59 0.49 1.42 0.03 2.66 1.05 1.56 0.03 0.01 0.03 0.36 0.03 0.16 1.80 3.65 9.54 1.74 0.58 1.03
42 2023-10-21 17.78 15.39 0.73 2.36 0.03 2.96 0.77 1.92 0.08 0.05 0.02 0.45 0.05 0.25 2.38 4.63 8.18 2.11 0.63 1.25
43 2023-10-28 17.89 15.78 1.16 5.47 0.03 5.19 0.68 2.59 0.10 0.03 0.02 0.55 0.06 0.23 3.25 6.76 8.11 2.16 0.55 1.41
44 2023-11-04 17.74 13.91 2.63 10.75 0.10 8.32 1.08 3.35 0.10 0.03 0.10 0.71 0.12 0.31 4.07 7.77 7.82 3.35 0.83 2.07
45 2023-11-11 18.17 12.43 4.93 16.19 0.07 9.83 1.18 4.19 0.14 0.04 0.06 0.97 0.22 0.44 5.12 7.68 7.03 4.43 1.29 2.71
46 2023-11-18 18.80 11.96 7.24 20.23 0.10 13.89 1.42 5.43 0.16 0.05 0.06 1.49 0.09 0.57 5.85 7.54 7.18 6.33 1.38 3.60
47 2023-11-25 19.31 11.76 8.81 24.27 0.13 15.25 1.25 6.91 0.12 0.04 0.07 2.13 0.13 0.80 6.81 6.66 8.10 8.69 1.79 4.79
48 2023-12-02 18.03 12.12 11.62 24.04 0.19 18.07 0.76 9.40 0.26 0.03 0.15 3.18 0.08 1.20 6.99 6.87 8.92 9.47 3.11 6.08
49 2023-12-09 17.53 12.61 14.74 21.12 0.23 19.13 1.43 11.34 0.29 0.06 0.05 4.21 0.19 1.60 7.38 7.29 10.09 12.26 5.40 7.54
50 2023-12-16 17.78 13.10 15.32 17.31 0.23 26.42 1.97 13.93 0.36 0.06 0.02 7.50 0.15 2.48 7.26 8.61 10.78 13.19 6.42 8.55
51 2023-12-23 16.81 14.09 16.78 12.50 0.18 28.53 2.27 16.69 0.45 0.05 0.02 10.44 0.19 3.30 7.29 9.16 8.97 15.23 7.40 9.92
52 2023-12-30 15.35 15.53 18.18 7.93 0.09 33.97 3.30 20.32 0.52 0.07 0.01 12.58 0.23 4.04 7.41 10.59 6.72 17.80 7.89 10.97
1 2024-01-06 14.51 15.03 14.49 4.54 0.08 30.93 4.58 19.59 0.60 0.07 0.00 10.34 0.22 3.87 7.10 10.34 5.26 15.62 8.37 10.84
2 2024-01-13 13.03 13.38 11.16 2.21 0.11 26.80 5.46 19.11 0.56 0.05 0.01 11.01 0.29 3.91 6.26 9.07 4.32 14.05 7.45 10.24
3 2024-01-20 11.35 12.21 10.28 1.40 0.04 28.20 9.13 18.95 0.79 0.14 0.01 12.75 0.35 4.70 6.13 8.43 3.42 15.56 7.90 10.95
4 2024-01-27 10.19 11.30 11.10 0.91 0.05 27.01 12.34 18.82 1.08 0.14 0.00 12.74 0.41 5.17 5.85 7.96 2.33 15.88 8.38 11.89
5 2024-02-03 9.34 11.51 11.28 0.76 0.03 23.66 15.78 19.15 1.48 0.28 0.01 14.84 0.41 5.77 5.91 7.15 2.19 16.33 8.77 12.14
6 2024-02-10 8.79 11.88 10.37 0.67 0.04 23.36 15.68 18.80 1.74 0.34 0.01 16.23 0.44 6.22 5.21 5.78 2.10 15.79 7.98 12.32
7 2024-02-17 8.12 11.79 9.43 0.57 0.02 24.22 15.48 18.53 2.18 0.29 0.00 17.02 0.35 6.56 4.49 5.13 2.16 15.53 8.42 11.89
8 2024-02-24 7.49 11.73 8.01 0.57 0.06 28.62 12.42 18.57 3.17 0.49 0.02 16.79 0.45 6.61 4.78 4.53 2.12 15.47 8.04 11.28
9 2024-03-02 7.03 11.18 6.72 0.63 0.12 29.30 11.04 18.13 4.03 0.70 0.00 15.45 0.74 6.25 3.79 3.70 2.50 15.62 7.59 10.52
10 2024-03-09 6.25 11.41 5.55 0.63 0.16 29.65 8.51 16.84 5.12 0.77 0.00 14.86 0.81 6.42 3.63 2.80 3.10 14.97 6.92 9.92
11 2024-03-16 6.11 11.58 4.49 0.52 0.26 24.27 6.74 14.55 4.90 1.15 0.01 13.11 1.05 6.86 3.17 2.18 3.71 12.11 6.29 9.33
Figure 2: Positive tests (%) of other respiratory viruses reported by participating laboratories in Canada by surveillance week compared to average and range from 2014-2015 to 2019-2020 season
Figure 2

Shaded area represents the maximum and minimum % of respiratory virus tests positive reported by week from seasons 2014-2015 to 2019-2020

Note: Changes to testing practices during the COVID-19 pandemic may cause substantial changes to indicator estimates from previous years. Collection of laboratory testing practice meta-data to understand these changes is ongoing. Interpret trends with caution.

Note: Data from week 11 of the 2019-2020 season onwards are excluded from the historical comparison due to the COVID-19 pandemic.

Note: % Tests Positive scale changes across the dashed line

Figure 2: Positive tests (%) of other respiratory viruses reported by participating laboratories in Canada by surveillance week compared to average and range from 2014-2015 to 2019-2020 season
Week Week end 2023-2024 EV/RV% 2022-2023 EV/RV% 2021-2022 EV/RV% Max EV/RV% Base Min EV/RV% Base Av EV/RV% Base 2023-2024 HPIV% 2022-2023 HPIV% 2021-2022 HPIV% Max HPIV% Base Min HPIV% Base Av HPIV% Base 2023-2024 ADV% 2022-2023 ADV% 2021-2022 ADV% Max ADV% Base Min ADV% Base Av ADV% Base 2023-2024 HMPV% 2022-2023 HMPV% 2021-2022 HMPV% Max HMPV% Base Min HMPV% Base Av HMPV% Base 2023-2024 HCoV% 2022-2023 HCoV% 2021-2022 HCoV% Max HCoV% Base Min HCoV% Base Av HCoV% Base
35 2023-09-02 12.50 15.47 21.96 27.19 22.44 24.71 1.99 2.80 5.99 3.16 1.15 2.44 1.62 2.28 1.18 1.74 0.99 1.43 0.34 1.80 0.23 2.04 0.10 0.78 0.28 0.53 1.05 0.76 0.18 0.45
36 2023-09-09 14.85 16.22 18.59 30.69 23.30 26.31 1.49 3.21 4.93 3.31 1.35 2.32 1.52 2.18 1.15 2.85 1.42 1.87 0.39 1.81 0.24 0.84 0.10 0.48 0.42 0.38 0.62 0.38 0.12 0.22
37 2023-09-16 18.29 21.73 27.46 33.58 27.74 31.69 1.60 3.02 5.97 3.26 1.65 2.40 1.47 2.10 0.81 2.44 1.38 1.86 0.39 1.38 0.17 1.61 0.00 0.51 0.23 0.28 0.44 0.56 0.00 0.26
38 2023-09-23 20.25 23.50 33.19 39.57 32.80 35.83 1.77 2.42 4.73 2.87 1.92 2.33 0.93 1.58 0.82 2.04 1.11 1.63 0.38 1.61 0.37 1.43 0.06 0.48 0.46 0.32 0.67 1.36 0.06 0.43
39 2023-09-30 18.52 22.89 30.01 40.59 34.87 37.68 1.32 3.09 8.12 3.01 1.70 2.24 1.15 2.21 1.14 2.27 1.04 1.66 0.51 1.43 0.17 0.72 0.05 0.29 0.28 0.59 0.62 0.66 0.07 0.45
40 2023-10-07 17.45 19.32 26.26 41.29 33.00 35.43 1.34 3.69 8.19 3.28 1.90 2.43 1.41 1.79 1.31 2.25 1.39 1.82 0.32 1.49 0.16 0.92 0.05 0.34 0.26 0.93 0.57 1.08 0.22 0.59
41 2023-10-14 15.74 16.70 22.91 33.62 26.94 29.93 1.28 3.52 10.46 3.70 1.96 2.75 1.38 2.03 1.37 1.91 1.28 1.70 0.37 1.66 0.20 0.95 0.04 0.46 0.32 0.99 1.69 0.70 0.00 0.34
42 2023-10-21 13.12 12.95 22.16 32.62 24.54 27.86 1.59 4.22 10.01 3.89 2.64 3.21 1.43 1.65 2.54 2.39 1.47 1.86 0.46 1.58 0.15 0.89 0.15 0.40 0.17 1.16 1.07 1.18 0.20 0.49
43 2023-10-28 12.52 11.05 19.64 28.73 21.67 24.95 1.21 4.41 9.38 3.98 3.18 3.54 1.48 1.79 1.15 2.42 1.63 1.96 0.46 1.79 0.36 1.64 0.12 0.58 0.38 1.86 1.05 2.35 0.27 0.75
44 2023-11-04 10.83 10.23 21.45 23.82 16.75 21.38 1.44 4.14 10.28 4.81 2.94 3.72 1.76 2.02 1.42 2.88 1.18 2.21 0.55 1.79 0.77 1.08 0.23 0.48 0.37 2.54 2.21 2.59 0.21 0.88
45 2023-11-11 10.70 7.77 22.39 23.08 15.17 20.56 1.65 3.90 9.97 5.42 2.53 4.01 1.45 1.99 1.63 2.68 2.02 2.42 0.60 2.06 0.64 1.30 0.04 0.77 0.42 3.00 2.57 2.74 0.52 0.96
46 2023-11-18 8.64 6.93 21.37 22.77 15.28 19.24 1.39 3.97 8.29 5.72 1.62 4.14 2.03 1.87 2.51 2.90 1.99 2.52 0.79 1.89 0.99 1.43 0.18 0.81 0.65 3.54 2.99 3.32 0.46 1.25
47 2023-11-25 7.62 4.88 18.54 20.84 12.15 16.09 1.55 3.63 7.04 7.00 2.36 4.72 1.90 1.89 1.94 2.95 1.83 2.35 1.00 1.78 1.01 2.02 0.09 0.90 0.65 3.24 3.90 3.26 0.37 1.25
48 2023-12-02 6.79 4.74 16.64 16.72 12.69 13.84 1.51 3.04 5.78 6.14 3.03 4.18 2.15 1.87 1.89 3.34 1.66 2.49 0.91 1.86 1.48 1.94 0.31 1.09 0.76 3.94 4.94 4.30 1.00 2.04
49 2023-12-09 6.00 4.09 14.57 16.32 10.72 13.07 1.39 3.03 3.97 5.65 2.94 4.19 1.83 1.68 2.48 3.03 1.84 2.50 1.20 1.93 1.22 2.80 0.49 1.48 1.12 4.48 6.58 5.19 0.84 2.53
50 2023-12-16 5.90 4.58 12.40 13.85 8.43 10.91 1.46 2.98 3.23 5.95 2.54 4.22 2.00 2.29 2.72 3.13 1.49 2.42 1.31 1.92 1.08 3.32 0.46 1.68 1.47 5.13 7.26 6.04 1.54 3.16
51 2023-12-23 5.56 4.49 9.95 14.18 8.81 10.48 1.35 3.09 3.01 6.71 2.94 3.95 1.55 1.76 2.54 3.20 1.36 2.04 1.59 2.23 1.20 4.39 0.37 2.47 1.77 5.28 8.11 6.68 1.87 3.72
52 2023-12-30 4.71 4.50 7.71 14.41 6.24 9.26 1.35 3.32 2.13 5.08 2.87 3.75 1.76 1.80 1.92 2.59 1.20 1.76 1.76 2.75 1.00 3.81 0.41 2.49 2.48 4.73 10.33 6.73 2.78 4.73
1 2024-01-06 4.80 4.19 5.71 11.09 4.36 7.42 1.48 3.63 1.84 5.08 2.68 3.34 1.48 1.88 1.84 2.67 0.85 1.54 2.20 2.94 0.72 4.45 0.28 2.74 3.06 4.40 9.27 7.77 3.07 5.16
2 2024-01-13 4.43 4.71 3.98 9.55 4.31 6.79 1.17 3.24 1.19 4.12 2.46 3.05 1.25 1.87 1.13 2.15 0.87 1.37 1.64 2.61 0.38 4.76 0.42 2.69 3.19 4.01 7.46 7.89 2.84 5.45
3 2024-01-20 4.59 6.68 3.12 8.42 4.44 6.01 1.08 2.92 0.76 3.25 2.59 2.82 1.11 1.97 1.34 2.10 1.15 1.45 2.20 2.56 0.24 5.56 0.47 3.18 3.90 3.46 4.97 7.90 4.17 6.11
4 2024-01-27 4.37 8.22 2.60 9.04 4.89 6.41 1.16 2.78 0.64 3.12 1.77 2.55 1.56 2.35 1.18 1.83 1.11 1.49 2.11 2.71 0.23 5.19 0.55 3.05 5.19 2.63 3.92 7.86 3.79 6.09
5 2024-02-03 5.02 8.94 3.02 9.79 6.06 6.94 1.45 2.70 0.48 3.48 1.70 2.39 1.62 2.44 1.57 1.93 1.36 1.62 2.27 2.96 0.25 5.70 0.58 3.34 5.10 3.20 2.83 8.49 4.55 6.84
6 2024-02-10 6.26 9.97 3.86 9.89 6.16 6.98 1.56 2.68 0.51 2.89 1.57 2.19 1.84 2.14 1.44 1.74 1.25 1.51 2.54 3.73 0.42 5.57 0.65 3.48 6.80 2.64 3.01 8.57 3.48 6.75
7 2024-02-17 6.18 9.87 4.46 8.95 6.00 7.04 1.54 2.63 0.44 3.20 1.42 2.11 1.22 2.31 1.52 1.61 1.30 1.51 2.82 4.41 0.44 6.05 1.45 3.96 7.73 3.14 3.24 8.02 4.35 6.52
8 2024-02-24 6.21 9.55 6.31 8.35 5.20 6.94 1.84 2.55 0.73 3.21 1.31 2.25 1.30 2.86 1.85 2.00 1.38 1.66 3.15 4.29 0.53 5.74 1.19 4.19 8.28 3.07 3.67 8.29 4.21 6.61
9 2024-03-02 6.48 9.77 7.80 9.03 5.73 7.75 2.40 3.07 0.60 3.35 1.41 2.44 1.65 2.75 1.90 1.92 1.09 1.40 3.92 4.72 0.40 6.42 1.87 4.46 7.09 3.41 3.32 8.01 5.09 6.87
10 2024-03-09 6.40 9.42 8.24 10.16 5.53 8.08 2.72 2.77 0.68 4.18 1.19 2.69 1.27 2.79 1.98 2.23 1.50 1.78 4.53 5.05 0.51 6.74 2.26 4.94 6.89 3.71 3.86 8.34 4.28 6.99
11 2024-03-16 6.34 8.77 8.97 9.45 7.15 8.22 3.21 3.48 0.66 4.58 1.35 3.00 1.21 2.39 1.88 2.32 1.23 1.69 5.08 5.07 0.59 7.94 2.52 4.87 7.22 3.70 3.25 8.02 4.35 6.23

Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests

Figure 3: Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests (%) in Canada by region by surveillance week
Figure 3

Note: Differences in positivity between jurisdictions can reflect differences in testing practices. Please interpret with caution.

Figure 3: Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests (%) in Canada by region by surveillance week
Week Week end Can Tests SARS-CoV-2% Atl Tests SARS-CoV-2% QC Tests SARS-CoV-2% ON Tests SARS-CoV-2% Pr Tests SARS-CoV-2% BC Tests SARS-CoV-2% Terr Tests SARS-CoV-2%
35 2023-09-02 25656 14.40 2110 16.92 9351 16.30 6230 12.39 5192 10.59 2651 18.03 122 11.48
36 2023-09-09 28237 15.92 2346 20.20 10215 17.37 6939 15.46 5968 11.90 2640 16.70 129 17.05
37 2023-09-16 31790 16.49 2567 18.62 11678 18.11 7337 15.66 6948 12.12 3111 20.64 149 10.07
38 2023-09-23 36264 18.60 2775 18.38 13455 20.48 8514 18.38 7969 14.23 3377 22.59 174 10.34
39 2023-09-30 40587 19.59 3126 22.65 15431 21.30 9291 17.86 8658 15.65 3895 23.59 186 12.90
40 2023-10-07 42173 19.81 3544 24.41 15684 22.19 9349 17.61 9198 15.96 4202 20.75 196 12.24
41 2023-10-14 38463 17.55 3583 20.74 12605 18.30 8426 15.27 9625 16.77 4047 19.13 177 14.69
42 2023-10-21 39350 17.78 3493 19.70 12590 18.63 9300 16.86 10040 17.16 3737 17.13 190 17.37
43 2023-10-28 37286 17.89 3095 17.74 12003 18.29 9276 19.35 9450 17.05 3262 14.87 200 17.50
44 2023-11-04 38183 17.74 2965 17.91 11975 18.42 9060 17.09 10341 18.12 3648 15.98 194 15.98
45 2023-11-11 38722 18.17 3122 20.12 11815 19.90 9607 18.24 10448 16.98 3545 14.41 185 10.81
46 2023-11-18 41432 18.80 3186 22.47 13182 20.21 10470 20.36 11134 16.80 3245 12.14 215 5.12
47 2023-11-25 42304 19.31 3490 22.35 12938 21.52 10880 22.17 11422 15.57 3385 11.96 189 6.35
48 2023-12-02 44713 18.03 3648 21.98 14100 22.18 11174 20.06 11903 12.58 3639 10.31 249 7.63
49 2023-12-09 46876 17.53 3654 20.17 14467 22.78 11644 18.67 12452 12.41 4272 10.30 387 6.98
50 2023-12-16 48215 17.78 4065 18.60 15835 23.97 12142 18.69 12089 11.16 3746 10.25 338 6.21
51 2023-12-23 48372 16.81 4353 15.81 16682 22.12 11548 18.73 11472 9.91 3952 10.55 365 9.86
52 2023-12-30 46997 15.35 4234 14.67 15739 19.65 11522 17.68 10314 9.95 4930 8.64 258 5.04
1 2024-01-06 48060 14.51 4471 12.68 15874 17.71 11545 16.83 10577 10.62 5300 9.57 293 7.17
2 2024-01-13 44189 13.03 4333 11.98 13921 14.75 11346 14.29 9475 9.91 4862 12.48 252 6.35
3 2024-01-20 38190 11.35 3750 10.64 11599 11.60 9942 12.87 8591 9.92 4141 10.92 167 4.19
4 2024-01-27 37089 10.19 3784 9.49 11052 9.79 9238 11.40 8358 8.95 4459 11.89 198 4.04
5 2024-02-03 36771 9.34 3908 8.75 10995 8.58 9011 9.75 8265 9.56 4420 10.63 172 5.81
6 2024-02-10 34740 8.79 3499 8.80 10544 7.33 8519 8.48 8042 10.12 3940 10.74 196 7.14
7 2024-02-17 35098 8.12 3185 8.92 11071 6.64 8901 7.48 8021 9.21 3722 11.04 198 7.07
8 2024-02-24 34146 7.49 3098 8.23 10925 5.10 8078 6.82 7890 8.66 3872 12.45 283 10.25
9 2024-03-02 33779 7.03 2992 7.02 10468 4.88 8299 6.21 7831 8.42 3972 11.76 217 6.45
10 2024-03-09 32392 6.25 3112 7.42 9479 3.46 7794 4.68 7843 7.71 3860 12.31 304 6.25
11 2024-03-16 32252 6.11 3346 6.90 9383 3.04 7587 5.47 7742 7.38 3901 11.48 293 7.51

Positive influenza (Flu) tests

Figure 4: Positive influenza (Flu) tests (%) in Canada by region by surveillance week
Figure 4
Figure 4: Positive influenza (Flu) tests (%) in Canada by region by surveillance week
Week Week end Can Tests Can A% Can B% Atl Tests Atl A% Atl B% QC Tests QC A% QC B% ON Tests ON A% ON B% Pr Tests Pr A% Pr B% BC Tests BC A% BC B% Terr Tests Terr A% Terr B%
35 2023-09-02 14543 0.69 0.06 984 0.00 0.00 3339 0.24 0.15 4324 0.39 0.09 3654 0.57 0.00 2158 2.46 0.00 84 2.38 0.00
36 2023-09-09 15430 0.43 0.06 1047 0.00 0.00 3649 0.19 0.03 4455 0.31 0.09 4069 0.37 0.05 2117 1.46 0.09 93 0.00 0.00
37 2023-09-16 18035 0.48 0.03 1216 0.08 0.00 4174 0.41 0.07 5145 0.29 0.00 4705 0.40 0.04 2703 1.29 0.04 92 0.00 0.00
38 2023-09-23 20121 0.51 0.02 1388 0.07 0.00 4734 0.30 0.00 5652 0.21 0.05 5325 0.62 0.02 2928 1.47 0.00 94 0.00 0.00
39 2023-09-30 21529 0.51 0.09 1403 0.14 0.07 4847 0.21 0.08 6186 0.37 0.11 5370 0.48 0.11 3598 1.36 0.06 125 0.00 0.00
40 2023-10-07 23658 0.64 0.05 1775 0.34 0.00 5628 0.37 0.04 6456 0.31 0.00 5803 0.74 0.16 3878 1.60 0.05 118 0.00 0.00
41 2023-10-14 23208 0.49 0.03 1938 0.57 0.00 4978 0.22 0.06 6283 0.30 0.00 6067 0.73 0.05 3828 0.73 0.03 114 0.00 0.00
42 2023-10-21 24067 0.73 0.08 2029 0.69 0.05 5110 0.37 0.02 6834 0.47 0.07 6370 1.13 0.13 3599 1.06 0.11 125 0.00 0.00
43 2023-10-28 23268 1.16 0.10 1979 0.96 0.00 5450 0.64 0.11 6814 0.50 0.06 5872 2.33 0.17 3039 1.45 0.10 114 0.88 0.00
44 2023-11-04 25317 2.63 0.10 1914 1.25 0.05 5705 0.63 0.07 6996 0.51 0.06 6996 6.80 0.17 3562 2.58 0.11 144 2.08 0.00
45 2023-11-11 26520 4.93 0.14 2069 2.03 0.14 5970 0.84 0.07 7240 1.22 0.07 7656 12.87 0.26 3460 3.96 0.14 125 4.00 0.00
46 2023-11-18 28583 7.24 0.16 2219 3.11 0.09 6454 1.36 0.09 7797 2.68 0.15 8734 18.14 0.26 3258 3.59 0.12 121 2.48 0.00
47 2023-11-25 29879 8.81 0.12 2521 4.60 0.04 6561 2.04 0.06 8070 2.69 0.02 9078 21.15 0.28 3517 6.43 0.09 132 15.15 0.00
48 2023-12-02 32859 11.62 0.26 2743 4.89 0.11 7199 3.78 0.15 8447 4.45 0.17 10485 24.44 0.47 3836 10.79 0.21 149 38.93 0.00
49 2023-12-09 34573 14.74 0.29 2817 9.66 0.11 8141 7.14 0.12 8466 7.08 0.21 11298 26.93 0.57 3590 13.12 0.11 261 49.81 0.00
50 2023-12-16 38612 15.32 0.36 3363 12.73 0.09 10087 11.63 0.12 9265 8.47 0.41 11116 24.56 0.71 4496 14.23 0.16 285 56.49 0.00
51 2023-12-23 40839 16.78 0.45 3820 19.08 0.31 12090 15.38 0.12 9246 11.39 0.51 10656 21.67 0.91 4747 16.64 0.29 280 40.36 0.00
52 2023-12-30 42481 18.18 0.52 3874 20.99 0.36 13501 19.37 0.07 9830 15.02 0.63 9719 17.61 1.24 5352 18.89 0.24 205 46.34 0.00
1 2024-01-06 43260 14.49 0.60 4132 17.91 0.36 13858 17.30 0.22 9869 11.67 0.54 9519 11.29 1.45 5634 14.55 0.39 248 33.47 0.00
2 2024-01-13 40233 11.16 0.56 3864 15.79 0.31 12702 15.32 0.19 9980 9.08 0.59 8491 5.94 1.33 4963 9.83 0.32 233 15.88 0.43
3 2024-01-20 35211 10.28 0.79 3422 14.23 0.94 11099 14.72 0.36 8812 8.65 0.45 7341 4.09 2.07 4397 9.71 0.34 140 5.71 0.00
4 2024-01-27 35174 11.10 1.08 3461 14.59 1.36 11277 17.65 0.28 8274 8.87 0.59 7261 2.31 2.91 4722 10.67 0.87 179 2.79 0.00
5 2024-02-03 35522 11.28 1.48 3608 14.61 2.02 12036 19.09 0.61 7738 8.30 1.02 7380 1.91 3.20 4626 8.58 1.25 134 2.24 2.99
6 2024-02-10 33996 10.37 1.74 3230 12.38 1.98 11857 18.01 1.05 7402 7.23 1.50 7229 1.77 3.28 4119 7.99 1.24 159 0.00 3.14
7 2024-02-17 33917 9.43 2.18 2882 8.78 2.74 11966 16.61 1.53 7689 7.40 1.87 7229 1.58 3.62 4006 6.81 1.40 145 1.38 11.03
8 2024-02-24 33294 8.01 3.17 2914 7.41 2.88 11748 14.22 2.63 7190 6.38 2.35 7029 1.07 5.65 4225 5.80 1.82 188 0.53 9.57
9 2024-03-02 32543 6.72 4.03 2834 7.13 4.13 11373 10.92 4.28 7133 5.72 2.90 6806 1.59 5.80 4231 5.25 1.96 166 2.41 13.25
10 2024-03-09 31607 5.55 5.12 2826 7.01 6.37 10777 8.84 5.27 6784 4.88 4.07 6829 1.29 6.63 4160 4.33 2.81 231 2.16 9.96
11 2024-03-16 25733 4.49 4.90 3170 6.03 4.95 7663 6.00 5.19 6837 4.01 3.76 3894 1.52 7.50 3941 4.34 3.50 228 0.44 8.77

Positive respiratory syncytial virus (RSV) tests

Figure 5: Positive respiratory syncytial virus (RSV) tests (%) in Canada by region by surveillance week
Figure 5
Figure 5: Positive respiratory syncytial virus (RSV) tests (%) in Canada by region by surveillance week
Week Week end Can Tests RSV% Atl Tests RSV% QC Tests RSV% ON Tests RSV% Pr Tests RSV% BC Tests RSV% Terr Tests RSV%
35 2023-09-02 13610 0.58 969 0.00 2540 1.14 4324 0.81 3535 0.20 2158 0.32 84 1.19
36 2023-09-09 14361 0.71 1047 0.57 2750 1.64 4455 0.88 3915 0.18 2101 0.24 93 0.00
37 2023-09-16 16808 0.82 1201 0.25 3181 1.67 5138 1.01 4494 0.38 2702 0.41 92 1.09
38 2023-09-23 18782 1.15 1381 1.30 3652 2.27 5652 1.43 5075 0.37 2928 0.51 94 0.00
39 2023-09-30 20217 1.14 1392 0.79 3788 2.38 6186 1.42 5128 0.43 3598 0.56 125 0.00
40 2023-10-07 22042 1.35 1761 0.28 4333 2.75 6456 1.95 5496 0.36 3878 0.72 118 0.00
41 2023-10-14 21748 1.80 1927 0.83 3897 3.70 6281 2.48 5701 0.63 3828 1.04 114 0.00
42 2023-10-21 22479 2.38 2015 0.69 3889 4.78 6834 3.72 6017 0.58 3599 1.25 125 0.00
43 2023-10-28 21745 3.25 1970 1.78 4234 6.24 6814 4.21 5574 1.22 3039 1.74 114 0.00
44 2023-11-04 23657 4.07 1904 2.15 4506 6.88 6997 5.80 6544 1.79 3562 2.36 144 2.78
45 2023-11-11 24764 5.12 2058 2.77 4680 7.97 7241 7.62 7201 2.14 3459 3.58 125 6.40
46 2023-11-18 26517 5.85 2195 2.41 4910 10.14 7796 7.91 8237 2.87 3258 4.27 121 7.44
47 2023-11-25 27491 6.81 2363 4.70 4975 11.82 8068 8.66 8508 3.24 3445 5.28 132 11.36
48 2023-12-02 30258 6.99 2549 5.88 5533 11.46 8447 8.49 9797 3.57 3783 6.66 149 8.72
49 2023-12-09 31232 7.38 2665 7.69 5930 11.11 8465 7.40 10436 4.53 3475 9.35 261 6.90
50 2023-12-16 34607 7.26 3004 8.46 7537 9.73 9261 5.99 10173 5.17 4347 9.50 285 10.53
51 2023-12-23 35988 7.29 3258 9.45 8774 9.14 9244 4.64 9820 6.47 4615 9.36 277 6.14
52 2023-12-30 37639 7.41 3431 8.57 9849 7.53 9829 4.62 9130 8.48 5196 9.49 204 15.69
1 2024-01-06 37934 7.10 3630 9.12 9953 7.31 9871 4.03 8828 7.56 5404 9.88 248 13.71
2 2024-01-13 35286 6.26 3383 9.16 9029 6.14 9975 3.27 7930 7.65 4737 7.81 232 17.67
3 2024-01-20 30825 6.13 2936 9.91 7837 5.82 8808 2.99 6890 8.21 4214 6.76 140 20.00
4 2024-01-27 30616 5.85 3067 10.01 7786 5.48 8260 2.62 6810 6.83 4514 7.35 179 24.02
5 2024-02-03 30446 5.91 3235 9.52 7985 5.07 7736 2.12 6932 8.18 4426 7.32 132 24.24
6 2024-02-10 29075 5.21 2949 10.07 7832 4.60 7404 1.62 6794 6.74 3937 6.27 159 20.75
7 2024-02-17 29028 4.49 2610 8.12 7969 4.56 7689 1.16 6769 6.04 3846 4.91 145 27.59
8 2024-02-24 28918 4.78 2715 7.18 8169 4.55 7190 1.14 6600 6.83 4057 5.57 187 29.41
9 2024-03-02 28626 3.79 2712 6.42 8150 3.99 7134 1.23 6368 4.35 4096 4.32 166 26.51
10 2024-03-09 27541 3.63 2700 6.52 7383 4.09 6784 0.90 6401 3.59 4043 3.96 230 31.30
11 2024-03-16 22627 3.17 3019 5.13 5108 3.72 6837 0.86 3636 3.63 3799 3.71 228 17.98

Positive human parainfluenza virus (HPIV) tests

Figure 6: Positive human parainfluenza virus (HPIV) tests (%) in Canada by region by surveillance week
Figure 6
Figure 6: Positive human parainfluenza virus (HPIV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests HPIV% Atl Tests HPIV% QC Tests HPIV% ON Tests HPIV% Pr Tests HPIV% BC Tests HPIV%
35 2023-09-02 6234 1.99 362 1.38 847 3.90 3406 1.85 984 1.02 635 2.05
36 2023-09-09 6321 1.49 355 1.69 868 2.19 3420 1.43 1133 0.97 545 1.65
37 2023-09-16 7419 1.60 401 2.49 1053 2.18 3886 1.34 1326 1.06 753 2.66
38 2023-09-23 8139 1.77 430 2.79 1122 2.85 4366 1.74 1445 0.90 776 1.42
39 2023-09-30 8627 1.32 401 1.25 1117 1.88 4948 1.33 1415 1.06 746 0.94
40 2023-10-07 8791 1.34 467 3.43 1178 2.04 4850 1.20 1541 0.39 755 1.85
41 2023-10-14 8879 1.28 491 1.63 1094 1.37 4898 1.16 1638 1.04 758 2.24
42 2023-10-21 9281 1.59 498 2.21 1050 1.52 5293 1.51 1707 1.46 733 2.18
43 2023-10-28 9085 1.21 474 1.48 1063 1.98 5223 0.96 1656 0.85 669 2.69
44 2023-11-04 9496 1.44 492 2.24 1067 2.06 5215 1.00 1938 1.24 784 3.57
45 2023-11-11 9826 1.65 467 2.78 1257 1.83 5242 1.11 2076 1.35 784 5.10
46 2023-11-18 10441 1.39 500 2.20 1426 1.33 5505 1.24 2191 0.87 819 3.42
47 2023-11-25 10872 1.55 620 1.77 1442 1.04 5708 1.47 2195 1.18 907 3.53
48 2023-12-02 11676 1.51 676 2.37 1587 1.32 5967 1.39 2463 1.10 983 2.95
49 2023-12-09 11621 1.39 668 1.65 1630 1.10 6040 1.44 2537 1.14 746 2.14
50 2023-12-16 12631 1.46 730 1.92 1664 0.72 6696 1.36 2459 1.46 1082 2.96
51 2023-12-23 12648 1.35 768 1.56 1857 0.54 6421 1.46 2408 0.79 1194 3.02
52 2023-12-30 12871 1.35 709 1.55 2004 0.85 6809 1.29 2168 0.97 1181 3.13
1 2024-01-06 13434 1.48 812 1.72 2046 0.59 7059 1.60 2288 1.18 1229 2.69
2 2024-01-13 13182 1.17 924 1.73 1882 0.53 7137 1.16 2111 1.09 1128 1.95
3 2024-01-20 11421 1.08 704 1.28 1843 0.49 6099 1.18 1772 1.13 1003 1.30
4 2024-01-27 11007 1.16 834 0.72 1793 0.28 5677 1.41 1707 1.41 996 1.31
5 2024-02-03 11179 1.45 794 1.26 1833 0.55 5534 1.66 1933 1.86 1085 1.29
6 2024-02-10 10714 1.56 782 0.77 1832 0.49 5194 1.73 1937 1.55 969 3.30
7 2024-02-17 10731 1.54 619 1.29 1863 0.54 5369 1.42 1898 2.32 982 2.75
8 2024-02-24 10456 1.84 632 0.47 1825 1.59 5115 1.82 1905 2.20 979 2.55
9 2024-03-02 10419 2.40 587 1.02 1800 1.11 5157 2.83 1793 2.90 1082 2.40
10 2024-03-09 9803 2.72 483 2.69 1681 1.84 4893 2.62 1744 3.67 1002 3.09
11 2024-03-16 8433 3.21 626 1.92 1152 2.17 4958 3.39 824 3.64 873 4.12

Positive adenovirus (ADV) tests

Figure 7: Positive adenovirus (ADV) tests (%) in Canada by region by surveillance week
Figure 7
Figure 7: Positive adenovirus (ADV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests ADV% Atl Tests ADV% QC Tests ADV% ON Tests ADV% Pr Tests ADV% BC Tests ADV%
35 2023-09-02 6238 1.62 362 1.93 851 2.70 3406 0.91 984 2.44 635 2.52
36 2023-09-09 6332 1.52 355 1.97 879 2.28 3420 0.82 1133 2.03 545 3.30
37 2023-09-16 7438 1.47 401 2.00 1071 2.43 3887 0.90 1326 1.96 753 1.86
38 2023-09-23 8149 0.93 429 1.17 1134 1.06 4365 0.62 1445 1.59 776 1.16
39 2023-09-30 8614 1.15 401 1.00 1129 2.04 4923 0.69 1415 1.63 746 2.01
40 2023-10-07 8809 1.41 467 2.36 1195 2.85 4851 0.66 1541 1.69 755 2.78
41 2023-10-14 8913 1.38 491 1.63 1111 3.42 4915 0.75 1638 1.47 758 2.11
42 2023-10-21 9286 1.43 498 1.20 1058 3.59 5292 0.76 1705 1.47 733 3.27
43 2023-10-28 9099 1.48 474 2.74 1077 3.62 5223 0.69 1656 1.63 669 2.99
44 2023-11-04 9514 1.76 492 2.03 1085 3.87 5215 1.04 1938 2.12 784 2.55
45 2023-11-11 9843 1.45 467 2.57 1274 2.98 5242 0.92 2076 1.64 784 1.40
46 2023-11-18 10452 2.03 500 4.60 1437 4.31 5505 0.94 2191 1.92 819 4.03
47 2023-11-25 10920 1.90 620 2.74 1461 3.97 5712 1.07 2194 1.50 911 3.84
48 2023-12-02 11737 2.15 676 3.25 1613 3.84 5967 1.36 2462 2.03 983 3.05
49 2023-12-09 11699 1.83 668 2.84 1652 3.75 6041 1.18 2537 1.26 746 3.62
50 2023-12-16 12719 2.00 730 2.19 1681 3.09 6696 1.78 2459 1.67 1082 2.40
51 2023-12-23 12035 1.55 768 1.82 1875 2.61 5726 0.89 2408 1.45 1194 3.02
52 2023-12-30 10983 1.76 709 2.12 2010 2.49 4852 0.80 2167 1.43 1181 4.74
1 2024-01-06 11675 1.48 812 1.11 2050 2.20 5219 0.75 2288 1.14 1229 4.15
2 2024-01-13 12078 1.25 924 1.52 1901 2.31 5943 0.59 2111 1.33 1126 2.49
3 2024-01-20 11459 1.11 704 1.56 1851 1.19 6091 0.64 1772 1.35 1003 2.89
4 2024-01-27 11062 1.56 834 2.88 1807 2.32 5675 0.78 1706 1.64 996 3.41
5 2024-02-03 11223 1.62 794 2.90 1841 2.55 5534 0.74 1933 1.55 1085 3.59
6 2024-02-10 10761 1.84 782 3.45 1852 2.59 5192 0.67 1935 1.45 969 5.88
7 2024-02-17 10779 1.22 619 1.29 1875 1.97 5369 0.60 1898 1.16 982 2.95
8 2024-02-24 10526 1.30 632 2.06 1837 2.01 5115 0.80 1905 0.89 979 2.96
9 2024-03-02 10484 1.65 587 4.26 1822 2.25 5157 1.01 1793 1.06 1082 2.87
10 2024-03-09 9895 1.27 483 1.86 1708 1.70 4893 0.69 1743 1.55 1002 2.30
11 2024-03-16 8480 1.21 626 1.44 1165 1.63 4959 0.75 824 1.82 873 2.52

Positive human metapneumovirus (HMPV) tests

Figure 8: Positive human metapneumovirus (HMPV) tests (%) in Canada by region by surveillance week
Figure 8
Figure 8: Positive human metapneumovirus (HMPV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests HMPV% Atl Tests HMPV% QC Tests HMPV% ON Tests HMPV% Pr Tests HMPV% BC Tests HMPV%
35 2023-09-02 6260 0.34 362 0.00 848 1.42 3407 0.21 1008 0.10 635 0.16
36 2023-09-09 6354 0.39 355 0.28 867 1.38 3423 0.20 1164 0.26 545 0.37
37 2023-09-16 7455 0.39 401 0.50 1053 0.76 3886 0.36 1362 0.07 753 0.53
38 2023-09-23 8194 0.38 429 0.00 1124 1.07 4365 0.14 1500 0.13 776 1.42
39 2023-09-30 8680 0.51 401 0.25 1118 0.89 4948 0.36 1467 0.34 746 1.34
40 2023-10-07 8828 0.32 457 0.44 1180 0.76 4853 0.14 1583 0.32 755 0.66
41 2023-10-14 8911 0.37 484 0.00 1096 1.00 4915 0.20 1658 0.12 758 1.32
42 2023-10-21 9321 0.46 498 0.20 1050 1.33 5298 0.32 1742 0.17 733 1.09
43 2023-10-28 9083 0.46 474 0.63 1066 1.41 5200 0.31 1674 0.18 669 0.75
44 2023-11-04 9519 0.55 492 0.20 1070 1.96 5218 0.17 1955 0.61 784 1.15
45 2023-11-11 9825 0.60 467 0.21 1256 2.15 5244 0.21 2074 0.63 784 0.89
46 2023-11-18 10315 0.79 500 0.40 1426 2.38 5505 0.36 2180 0.37 704 2.56
47 2023-11-25 10920 1.00 620 0.97 1442 2.57 5715 0.44 2210 0.59 911 2.96
48 2023-12-02 11703 0.91 676 0.89 1585 2.33 5965 0.47 2458 0.49 983 2.34
49 2023-12-09 11654 1.20 668 1.20 1635 2.39 6037 0.61 2513 1.95 746 0.94
50 2023-12-16 12683 1.31 730 1.78 1669 2.52 6707 0.63 2424 1.61 1082 2.77
51 2023-12-23 12659 1.59 768 1.56 1857 2.48 6415 0.78 2361 2.50 1194 2.85
52 2023-12-30 12881 1.76 709 2.26 2006 2.14 6809 0.98 2112 2.27 1181 4.49
1 2024-01-06 13431 2.20 812 1.85 2048 2.15 7012 1.07 2253 3.99 1229 5.78
2 2024-01-13 13207 1.64 924 1.41 1887 1.59 7144 0.62 2053 3.85 1126 4.26
3 2024-01-20 11426 2.20 704 1.56 1837 2.34 6103 1.23 1741 4.19 1003 4.79
4 2024-01-27 11026 2.11 834 1.92 1793 1.78 5678 1.13 1681 4.34 996 4.82
5 2024-02-03 11160 2.27 794 2.39 1831 2.46 5534 1.36 1880 2.87 1085 5.44
6 2024-02-10 10709 2.54 782 2.94 1828 2.63 5191 1.58 1908 2.62 969 7.12
7 2024-02-17 10757 2.82 619 2.91 1864 3.70 5376 2.14 1880 1.91 982 6.62
8 2024-02-24 10426 3.15 632 3.96 1825 2.79 5114 2.62 1818 2.31 979 7.76
9 2024-03-02 10398 3.92 587 3.75 1802 4.99 5157 3.37 1727 2.49 1082 7.30
10 2024-03-09 9822 4.53 483 5.38 1677 5.66 4902 4.41 1692 1.83 1002 7.58
11 2024-03-16 8482 5.08 626 7.67 1154 5.29 4971 4.61 825 3.64 873 7.10

Positive enterovirus/rhinovirus (EV/RV) tests

Figure 9: Positive enterovirus/rhinovirus (EV/RV) tests (%) in Canada by region by surveillance week
Figure 9
Figure 9: Positive enterovirus/rhinovirus (EV/RV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests EV/RV% Atl Tests EV/RV% QC Tests EV/RV% ON Tests EV/RV% Pr Tests EV/RV% BC Tests EV/RV%
35 2023-09-02 5345 12.50 362 20.72 N.A. N.A. 3409 10.44 966 14.60 608 15.79
36 2023-09-09 5414 14.85 355 25.35 N.A. N.A. 3423 12.80 1119 16.80 516 17.05
37 2023-09-16 6331 18.29 401 23.69 N.A. N.A. 3887 16.08 1314 22.37 722 19.81
38 2023-09-23 6991 20.25 429 27.51 N.A. N.A. 4365 17.11 1428 25.14 747 24.63
39 2023-09-30 7479 18.52 401 26.43 N.A. N.A. 4948 15.74 1398 22.17 715 25.31
40 2023-10-07 7559 17.45 467 23.55 N.A. N.A. 4853 14.77 1515 20.99 706 23.80
41 2023-10-14 7762 15.74 491 23.01 N.A. N.A. 4915 13.77 1612 16.00 717 23.15
42 2023-10-21 8204 13.12 498 22.09 N.A. N.A. 5298 10.82 1681 13.50 695 22.16
43 2023-10-28 7977 12.52 474 16.03 N.A. N.A. 5227 9.95 1624 15.58 637 23.23
44 2023-11-04 8385 10.83 492 17.07 N.A. N.A. 5218 8.39 1916 12.21 736 20.52
45 2023-11-11 8530 10.70 467 16.70 N.A. N.A. 5244 8.68 2051 10.48 743 21.53
46 2023-11-18 8958 8.64 500 14.20 N.A. N.A. 5506 6.79 2161 8.42 779 18.87
47 2023-11-25 9427 7.62 620 11.94 N.A. N.A. 5716 5.86 2186 7.55 883 15.63
48 2023-12-02 10068 6.79 676 9.76 N.A. N.A. 5970 5.19 2427 6.47 959 15.43
49 2023-12-09 9980 6.00 668 6.74 N.A. N.A. 6046 4.50 2516 6.20 695 17.70
50 2023-12-16 11005 5.90 730 7.81 N.A. N.A. 6708 4.62 2437 4.97 1059 14.45
51 2023-12-23 10800 5.56 768 6.51 N.A. N.A. 6434 3.73 2380 5.88 1154 14.47
52 2023-12-30 10881 4.71 709 5.50 N.A. N.A. 6808 3.30 2155 4.83 1145 12.31
1 2024-01-06 11366 4.80 812 4.43 N.A. N.A. 7012 3.76 2268 5.51 1197 9.69
2 2024-01-13 11322 4.43 924 4.22 N.A. N.A. 7146 3.20 2090 5.07 1089 11.48
3 2024-01-20 9562 4.59 704 4.26 N.A. N.A. 6103 3.16 1749 6.40 968 10.02
4 2024-01-27 9212 4.37 834 4.68 N.A. N.A. 5678 3.12 1695 6.02 961 8.43
5 2024-02-03 9317 5.02 794 5.54 N.A. N.A. 5534 3.27 1918 7.66 1035 9.08
6 2024-02-10 8831 6.26 782 8.82 N.A. N.A. 5191 4.26 1909 7.54 918 12.42
7 2024-02-17 8854 6.18 619 6.30 N.A. N.A. 5376 4.35 1882 8.29 941 12.01
8 2024-02-24 8645 6.21 632 5.85 N.A. N.A. 5114 4.99 1896 7.23 945 10.69
9 2024-03-02 8601 6.48 587 6.30 N.A. N.A. 5157 4.65 1773 7.61 1041 13.74
10 2024-03-09 8136 6.40 483 9.11 N.A. N.A. 4902 4.61 1729 7.46 956 12.45
11 2024-03-16 7290 6.34 626 6.55 N.A. N.A. 4971 5.03 819 6.96 841 12.84

Positive human coronavirus (HCoV) tests

Figure 10: Positive human coronavirus (HCoV) tests (%) in Canada by region by surveillance week
Figure 10
Figure 10: Positive human coronavirus (HCoV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests HCoV% Atl Tests HCoV% QC Tests HCoV% ON Tests HCoV% Pr Tests HCoV% BC Tests HCoV%
35 2023-09-02 5054 0.28 362 0.00 847 0.47 2230 0.13 1007 0.60 608 0.16
36 2023-09-09 5195 0.42 355 0.56 868 0.81 2285 0.09 1171 0.77 516 0.39
37 2023-09-16 6174 0.23 401 0.50 1053 0.47 2636 0.23 1362 0.00 722 0.14
38 2023-09-23 6796 0.46 429 0.00 1122 0.80 2995 0.40 1503 0.40 747 0.54
39 2023-09-30 7026 0.28 401 0.00 1117 0.45 3325 0.21 1468 0.48 715 0.14
40 2023-10-07 7305 0.26 467 0.21 1178 0.08 3390 0.18 1587 0.25 683 1.02
41 2023-10-14 7435 0.32 491 0.20 1094 0.73 3461 0.12 1672 0.60 717 0.14
42 2023-10-21 7697 0.17 498 0.20 1050 0.48 3707 0.05 1747 0.23 695 0.14
43 2023-10-28 7576 0.38 473 0.42 1065 0.38 3707 0.30 1694 0.53 637 0.47
44 2023-11-04 7754 0.37 476 0.21 1067 0.28 3508 0.43 1967 0.20 736 0.82
45 2023-11-11 8119 0.42 467 0.86 1187 0.51 3607 0.28 2115 0.38 743 0.81
46 2023-11-18 8674 0.65 500 0.20 1324 0.98 3838 0.42 2233 0.99 779 0.51
47 2023-11-25 9069 0.65 620 0.65 1357 0.96 3977 0.55 2232 0.54 883 0.91
48 2023-12-02 9880 0.76 676 0.74 1518 1.05 4241 0.42 2486 0.72 959 1.88
49 2023-12-09 9440 1.12 668 1.20 1523 1.64 4007 0.57 2547 1.33 695 2.30
50 2023-12-16 10458 1.47 730 0.41 1583 1.58 4616 1.47 2470 1.58 1059 1.79
51 2023-12-23 10483 1.77 768 1.30 1765 2.10 4389 1.66 2407 1.58 1154 2.43
52 2023-12-30 10328 2.48 709 1.55 1885 2.97 4422 2.49 2167 2.08 1145 2.97
1 2024-01-06 10903 3.06 812 2.96 1861 2.10 4722 3.37 2311 2.81 1197 3.93
2 2024-01-13 10891 3.19 924 3.03 1719 2.50 5030 3.14 2129 3.85 1089 3.31
3 2024-01-20 9525 3.90 704 5.11 1698 4.18 4360 3.78 1795 3.79 968 3.20
4 2024-01-27 9111 5.19 834 5.28 1640 5.49 3941 5.76 1735 4.27 961 3.95
5 2024-02-03 9137 5.10 794 4.79 1647 5.10 3717 6.27 1944 3.34 1035 4.44
6 2024-02-10 8766 6.80 782 5.37 1653 9.50 3456 7.00 1957 5.01 918 6.21
7 2024-02-17 8846 7.73 619 6.30 1700 8.12 3661 8.96 1925 6.39 941 5.95
8 2024-02-24 8547 8.28 632 7.28 1644 10.28 3417 8.17 1909 7.02 945 8.47
9 2024-03-02 8590 7.09 587 6.47 1643 7.49 3511 8.32 1808 5.53 1041 5.38
10 2024-03-09 7977 6.89 483 4.97 1521 6.97 3253 8.18 1764 5.50 956 5.96
11 2024-03-16 6719 7.22 626 4.95 1035 7.15 3363 8.24 854 6.56 841 5.59

Page details

Date modified: